A phase I/Ib study of olaparib and ASTX727 in BRCA 1/2- and HRD-mutated tumors.

Authors: Pamela N. Munster, Robin Kate Kelley, Susan Calabrese, Kelli Walker, Ethan Clark, Phu Lam, Savannah Berkley, Scott Thomas, Varun Monga

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps3183

Source: Full article

---

Abstract

TPS3183